Debatin KM - Search Results

1

Diversity of human leukemia xenograft mouse models: implications for disease biology.

Meyer LH, Debatin KM. Meyer LH, et al. Among authors: debatin km. Cancer Res. 2011 Dec 1;71(23):7141-4. doi: 10.1158/0008-5472.CAN-11-1732. Epub 2011 Nov 16. Cancer Res. 2011. PMID: 22088964 Review.

2

Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells.

Fulda S, Susin SA, Kroemer G, Debatin KM. Fulda S, et al. Among authors: debatin km. Cancer Res. 1998 Oct 1;58(19):4453-60. Cancer Res. 1998. PMID: 9766678

3

Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosis.

Beltinger C, Fulda S, Kammertoens T, Uckert W, Debatin KM. Beltinger C, et al. Among authors: debatin km. Cancer Res. 2000 Jun 15;60(12):3212-7. Cancer Res. 2000. PMID: 10866313

4

Murine models for experimental therapy of pediatric solid tumors with poor prognosis.

Beltinger C, Debatin KM. Beltinger C, et al. Among authors: debatin km. Int J Cancer. 2001 May 1;92(3):313-8. doi: 10.1002/ijc.1210. Int J Cancer. 2001. PMID: 11291063 Review.

5

Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol.

Fulda S, Debatin KM. Fulda S, et al. Among authors: debatin km. Cancer Res. 2004 Jan 1;64(1):337-46. doi: 10.1158/0008-5472.can-03-1656. Cancer Res. 2004. PMID: 14729643

6

Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspase.

Giagkousiklidis S, Vogler M, Westhoff MA, Kasperczyk H, Debatin KM, Fulda S. Giagkousiklidis S, et al. Among authors: debatin km. Cancer Res. 2005 Nov 15;65(22):10502-13. doi: 10.1158/0008-5472.CAN-05-0866. Cancer Res. 2005. PMID: 16288043

7

Meyer LH, Karawajew L, Schrappe M, Ludwig WD, Debatin KM, Stahnke K. Meyer LH, et al. Among authors: debatin km. Blood. 2006 Jun 1;107(11):4524-31. doi: 10.1182/blood-2005-08-3305. Epub 2006 Feb 7. Blood. 2006. PMID: 16467206 Free article.

8

Loss of caspase-8 expression does not correlate with MYCN amplification, aggressive disease, or prognosis in neuroblastoma.

Fulda S, Poremba C, Berwanger B, Häcker S, Eilers M, Christiansen H, Hero B, Debatin KM. Fulda S, et al. Among authors: debatin km. Cancer Res. 2006 Oct 15;66(20):10016-23. doi: 10.1158/0008-5472.CAN-05-4079. Cancer Res. 2006. PMID: 17047064

9

Activation of Akt predicts poor outcome in neuroblastoma.

Opel D, Poremba C, Simon T, Debatin KM, Fulda S. Opel D, et al. Among authors: debatin km. Cancer Res. 2007 Jan 15;67(2):735-45. doi: 10.1158/0008-5472.CAN-06-2201. Cancer Res. 2007. PMID: 17234785

10

Breaking chemoresistance and radioresistance with [213Bi]anti-CD45 antibodies in leukemia cells.

Friesen C, Glatting G, Koop B, Schwarz K, Morgenstern A, Apostolidis C, Debatin KM, Reske SN. Friesen C, et al. Among authors: debatin km. Cancer Res. 2007 Mar 1;67(5):1950-8. doi: 10.1158/0008-5472.CAN-06-3569. Cancer Res. 2007. PMID: 17332322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

538 results

Search Page

Filters